Who are our members?

Our members are clinicians, researchers, administrators, engineers, policymakers, and others passionate about improving health care delivery around the world.


countries represented


These discussions are very helpful, especially in opening the minds of people on which models work and which don't, which models are sustainable and which aren't. By exchanging knowledge and information on GHDonline, we can get the best models.

Manzi Anatole, MPH, Rwanda

Public Communities We provide a platform of online communities for health care professionals to connect and discuss challenges in care delivery. Our communities are led by experts in their respective fields. Learn more.

Expert Panels We host week-long, moderated online discussions around key issues in the health care delivery. Expert Panels focus on timely topics and highlight innovative approaches from diverse settings. Learn more.


End-of-life care is the term used to describe the support and medical care given during the time surrounding death. The care provided does not happen just in the moments before breathing finally stops and a heart ceases to beat. Rather, an individual may be living, and dying, with one or more chronic illnesses and require care for days, weeks, and sometimes even months. Personal preference, family, culture, faith and economics all intersect in this journey. This Expert Panel examines best practices for initiating conversations about end-of-life care. Learn more.


Digital clinical resources offer access to vital clinical information at the point of care and inform providers of the most recent advancements in medicine. This Expert Panel discusses how the recent expansion of these tools in the United States raises questions regarding their global uptake, the barriers restricting their use, and what can be done to overcome these roadblocks. Learn more.

We've hosted more than 50 different Expert Panels highlighting key issues experienced in the field. Learn more.


This panel explores methods for driving innovation and access in global health diagnostics for HIV, TB, malaria, and HPV. Our panelists share their experiences and expertise, and discuss what must be done to ensure these technologies are accessible to the world’s poorest and most vulnerable populations. Join us to discuss what must be done in order to develop delivery systems, business models, new technologies, interoperability standards, and governance mechanisms to ensure each patient will receive the right diagnostic at the right time. Learn more.


Enthusiasm for the new anti-tuberculosis drugs bedaquiline and delaminid is tempered by concerns about their potential to cause cardiotoxicity. This panel explores the risk of QT prolongation in emerging drug-resistant tuberculosis (DR-TB) therapy. Learn more.